SANDS CAPITAL LIFE SCIENCES PULSE FUND II, L.P. purchased 18.9% of their position (2.07M shares) of INHIBIKASE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $3.00M — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/24/2025ACC: 0001875620-25-000025
→
10% Owner
Since Oct 2024
+2.07M
Net shares
Net buyer
$3.00M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.07M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.07M
Price / share
$1.45
Trade value
$3M
% of position
18.9%
11/21/2025
10.95M→13.02M
Total
Net shares
+2.07M
Net value
$3M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/21/2025 | P · Purchase | +2.07M | $1.45 | $3M | 18.9% | 10.95M | 13.02M |
| Total | +2.07M | $3M | ||||||
Derivative Transactions0
No derivative transactions reported